Sign inCreate account

Report workspace tools

NCT07522294ACTIVE_NOT_RECRUITINGanonymous

Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision

Sponsor

Source record

Jeng-Fu You

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

da Vinci SP Surgical System

Indication / condition

AI-normalized

Rectal Neoplasms

Intervention

Source record

da Vinci SP Surgical System

Source & freshness

Source record

NCT ID

NCT07522294

Original source

ClinicalTrials.gov

Source last updated

Apr 17, 2026

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT07522294

Title

Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision

Sponsor

Jeng-Fu You

Status

ACTIVE_NOT_RECRUITING

Phase

NA

Condition raw

Rectal Neoplasms

Condition normalized

Rectal Neoplasms

Modality raw

colorectal cancer

Modality normalized

medical device

Target raw

da Vinci SP Surgical System

Target normalized

da Vinci SP Surgical System

Interventions

da Vinci SP Surgical System

Public preview

Source record

Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision is a NA clinical asset sponsored by Jeng-Fu You in Rectal Neoplasms, Rectal Cancer Patients, Rectal Benign Lesions. SEO and diligence focus: da Vinci SP Surgical System, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT07522294

Status

ACTIVE_NOT_RECRUITING

Phase

NA

Sponsor

Jeng-Fu You

Executive brief

Investment-Ready Snapshot

Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision is a NA clinical asset sponsored by Jeng-Fu You in Rectal Neoplasms, Rectal Cancer Patients, Rectal Benign Lesions. SEO and diligence focus: da Vinci SP Surgical System, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedApr 17, 2026
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT07522294

Indication

Rectal Neoplasms

Modality

medical device

Target

da Vinci SP Surgical System

Intervention

da Vinci SP Surgical System

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.